IRCCS Azienda Ospedaliero-Universitaria di Bologna at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
IRCCS Azienda Ospedaliero-Universitaria di Bologna brings 11 presentations to ASH 2026 in New Orleans. Its program centres on myeloproliferative neoplasms, myeloma and acute leukemia. It includes a score predicting thrombosis in myelofibrosis and dose optimization for the menin inhibitor enzomenib.
| Organization | ASH 2026 Attendance |
|---|---|
IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy | |
University of Bologna teaching hospital, the Sant'Orsola Polyclinic, home of the Seràgnoli Institute of Hematology. | Symposium Fri Dec 11 7:00am–10:00am Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention. Talk Sat Dec 12 9:30am–10:45am Preventing Progression and Overcoming Resistance in MPNs Moving myeloproliferative neoplasm care toward earlier disease-modifying therapy and molecular monitoring, and handling resistance to Janus kinase inhibitors. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 4:30pm–5:45pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tell us what you sell and we’ll find the people at IRCCS Azienda Ospedaliero-Universitaria di Bologna most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction